What’s the relationship between high blood pressure and Lupus Nephritis? Some
patients who have been diagnosed with Lupus Nephritis also have high blood
pressure at the same time. Indeed, Lupus Nephritis ( Berger’s disease) can
really suffer from high blood pressure. Lupus Nephropathy is a kind of kidney
disease and long time damage in kidney can really lead to increased blood
pressure.
Berger’s disease is a kind of renal glomerular nephritis. About 23% to 70%
patients with chronic renal glomerular nephritis will suffer from high blood
pressure with the disease developing. The more renal function declines, the
higher blood pressure will be. In addition, lesion in renal parenchyma and renal
tubules can also lead to high blood pressure such as insufficiency of chronic
pyelonephritis. Half of them can lead to high blood pressure.
Once diagnosed accompanied by high blood pressure, patients with Lupus
Nephritis should apply medicines which can lower blood pressure besides plasma
exchange, and other medicine such as monoclonal antibody, and so on. As for
medicine which can lower blood pressure, Chinese Medicine is a priority.
Firstly, Chinese Medicine can extend all levels of arteries, improve the
micro-blood circulation, increase the effective perfusion in the kidney, relieve
the insufficiency of blood and oxygen, increase the metabolism in partial area,
which can also accelerate the repair of renal intrinsic cells such as renal
arterial endothelial cells, thus relieving high blood pressure.
Secondly, Chinese Medicine can also inhibit the release of inflammatory
mediators and inactivate the materials which can lead to damage to the kidney,
thus reducing the further damage to the renal intrinsic cells, stopping the
development of renal fibrosis and treating high blood pressure
fundamentally.
At present, the theory in our Hospital is becoming more and more systematic.
At present, Chinese Medicine has becomes part of immunotherapy which is on the
basis of the theory that most kidney diseases are caused by immune disorder.
No comments:
Post a Comment